3-[N-(dibenzofuran-4-yl-methyl)amino]-N-hydroxy-4-methoxybenzamide

ID: ALA4869895

Chembl Id: CHEMBL4869895

PubChem CID: 164618548

Max Phase: Preclinical

Molecular Formula: C21H18N2O4

Molecular Weight: 362.39

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc(C(=O)NO)cc1NCc1cccc2c1oc1ccccc12

Standard InChI:  InChI=1S/C21H18N2O4/c1-26-19-10-9-13(21(24)23-25)11-17(19)22-12-14-5-4-7-16-15-6-2-3-8-18(15)27-20(14)16/h2-11,22,25H,12H2,1H3,(H,23,24)

Standard InChI Key:  LJYNCXNVPFKCRG-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4869895

    ---

Associated Targets(Human)

HDAC8 Tclin Histone deacetylase 8 (4516 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

HDAC8 Histone deacetylase 8 (483 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 362.39Molecular Weight (Monoisotopic): 362.1267AlogP: 4.33#Rotatable Bonds: 5
Polar Surface Area: 83.73Molecular Species: NEUTRALHBA: 5HBD: 3
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 9.21CX Basic pKa: 3.32CX LogP: 3.04CX LogD: 3.03
Aromatic Rings: 4Heavy Atoms: 27QED Weighted: 0.36Np Likeness Score: -0.68

References

1. Ghazy E, Heimburg T, Lancelot J, Zeyen P, Schmidtkunz K, Truhn A, Darwish S, Simoben CV, Shaik TB, Erdmann F, Schmidt M, Robaa D, Romier C, Jung M, Pierce R, Sippl W..  (2021)  Synthesis, structure-activity relationships, cocrystallization and cellular characterization of novel smHDAC8 inhibitors for the treatment of schistosomiasis.,  225  [PMID:34392190] [10.1016/j.ejmech.2021.113745]

Source